PharmaPatents Timely Insight on Emerging Legal Developments

Tag Archives: Reasonable Examiner

Will The Federal Circuit’s Therasense Decision Solve The McKesson Problem?

Posted in Duty of Disclosure; Federal Circuit Decisions; Inequitable Conduct

This week the Federal Circuit heard oral arguments in its en banc rehearing of Therasense, Inc. v. Becton, Dickinson & Co. As reflected in the en banc order, the court took this case en banc in order to reconsider—and hopefully reform—the law of inequitable conduct. The court’s decision could solve the McKesson problem and rein in the threat of inequitable conduct charges that drives practitioners to submit references even when they are not believed to be relevant to patentability. 
 

Continue reading this entry